In a German follow-up of both female and male patients treated for childhood cancer, the risk of infertility was assessed as 43% after ES and 31% after OS.[16] Our cohort of female OS patients showed a prompt increase in AMH during the first years after treatment, whereas FSH remained low. This evidence concerns the gene BRD2 and childhood malignant neoplasm.